GenScript Biotech (01877): The application for the new drug SoKwadmono Kifimab Injection has been accepted for review.

Intelligence Finance News App, Jun Shi Biology (01877) announced that recently, the company received the "Acceptance Notice" issued by the National Medical Products Administration. The company's product Rokezumab Injection (recombinant humanized anti-IL-17A monoclonal antibody injection, product code: JS005) for the treatment of moderate to severe plaque psoriasis in adults suitable for systemic treatment or phototherapy has been accepted for new drug marketing application.